Trial Search Results

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Cook Research Incorporated

Stanford Investigator(s):


  • Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation,
  • Device: Atrium iCAST™
  • Device: Zenith® Flex AAA Endovascular Graft




Inclusion Criteria:

   - An aortioiliac or iliac aneurysm

   - An unsuitable distal sealing site for a traditional Zenith iliac leg graft within the
   common lilac artery

Exclusion Criteria:

   - Less than 18 years of age

   - Inability or refusal to give informed consent

   - Disease considerations that would compromise patient safety or study outcomes

   - Pregnant, breast-feeding or planning on becoming pregnant prior to completion of the

   - Unwilling or unable to comply with the follow-up schedule

   - Simultaneously participating in another investigative device or drug study

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting